Vaccine
Antravax
Vaccine against bacterial anthrax as suspension for injection
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
| Active ingredient(s) | Posology* | Waiting time | Packaging |
|---|---|---|---|
Live attenuated bacillus anthracis, strain Sterne 34F2 | Subcutaneous route | Zero days | 50 mL (25 doses) 100 mL (50 doses) 250 mL (125 doses) |
Country Availability
Lebanon, Mexico, Spain.
If your country is not listed, please contact our export team.
Active ingredient(s)
Live attenuated bacillus anthracis, strain sterne 34F2……………………………………………………..0,5-1 x 10^7 spores
Indications
For active immunization of bovine and ovine livestock against bacterial anthrax caused by Bacillus anthracis.
Immunity is acquired at 3 weeks from vaccination and maintained for 1 year.
Special precautions
The vaccine may be pathogenic to humans.
Posology
Bovine: 2 mL/animal.
Ovine: 1 mL/animal.
First vaccination: From 3 months old.
Revaccination: Annually except in endemic areas in which revaccination should be every 6 months.
Waiting time
Zero days.
Packaging
Container with 50 mL.
With veterinary prescription.
Registry no.: 2857 ESP
